IRIDEX (NASDAQ:IRIX) Posts Quarterly Earnings Results

IRIDEX (NASDAQ:IRIX) posted its quarterly earnings results on Thursday. The medical equipment provider reported ($0.05) EPS for the quarter, Zacks reports. IRIDEX had a negative net margin of 22.79% and a negative return on equity of 192.95%.

IRIDEX Trading Down 1.8 %

IRIX stock traded down $0.02 on Thursday, reaching $0.88. The company’s stock had a trading volume of 104,431 shares, compared to its average volume of 39,800. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.85 and a current ratio of 1.54. The business has a fifty day simple moving average of $1.41 and a two-hundred day simple moving average of $1.60. The firm has a market cap of $14.69 million, a PE ratio of -1.32 and a beta of 0.94. IRIDEX has a 12-month low of $0.78 and a 12-month high of $3.65.

Analysts Set New Price Targets

Separately, StockNews.com initiated coverage on IRIDEX in a research note on Tuesday. They issued a “hold” rating on the stock.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.